EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC 4.0

Comprehensive molecular analyses for diagnosis and treatment guidance in an adult neuroblastoma patient

Damian T Rieke iD, Stefan Schwartz, Sebastian Ochsenreither, Björn Chapuy, Holger Amthauer, Hedwig E Deubzer iD, Annika Lehmann, Ulrich Keilholz, Eva Wardelmann, Christian Vokuhl, Angelika Eggert, Stefan Fröhling und 5 weitere

The Oncologist · 10.04.2026 · 31 (5)

DOI: 10.1093/oncolo/oyag132 ↗

Kurz gefasst

Fallbericht in der Zeitschrift The Oncologist, online erschienen am 06.04.2026. Verfasst von Damian T Rieke und 16 weiteren Autor:innen. Beteiligte Einrichtung: German Cancer Consortium (DKTK), Partner Site Berlin, a Partnership between DKFZ and Charité - Universitätsmedizin Berlin, Berlin 10117, Germany. Hauptthemen laut MEDLINE: Neuroblastoma. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCT Molecular Precision Oncology Program, DKFZ, and DKTK.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metastatic cancers of unknown primary (CUP) pose significant diagnostic and therapeutic challenges. We present the case of a 63-year old male patient with a CUP showing neuroendocrine differentiation, metastasized to the iliac bone, bone marrow, supraclavicular and retroperitoneal lymph nodes. Immunohistochemical and molecular profiling revealed strong pan-neurotrophic tyrosine kinase (Trk) expression without NTRK-gene fusion, corroborating the neural cell origin. Following molecular tumor board (MTB) discussion, genome-wide methylation profiling suggested the diagnosis of a neuroblastoma but results were below diagnostic thresholds. Subsequent imaging and laboratory findings confirmed an INRGSS stage M neuroblastoma, a rare finding in older adults. Despite multimodal therapy, including polychemotherapy and immunotherapy according to pediatric GPOH neuroblastoma guidelines, disease progression necessitated an experimental approach. Comprehensive molecular analysis and MTB discussion revealed several potential treatment targets, leading to subsequent treatment including dinutuximab beta, nivolumab, cabozantinib, I-131-mIBG radionuclide therapy and alpelisib, unfortunately, all followed by disease progression. This case demonstrates the potential of comprehensive molecular analysis including methylation profiling for diagnosis and treatment guidance in rare tumors. Additional research is urgently required to improve outcomes in elderly patients with neuroblastoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeuroblastomaHumansMaleMiddle Aged

Stichwörter der Autor:innen

Cancer of unknown primaryComprehensive molecular analysisMethylation analysisNeuroblastomaPrecision oncology

Autor:innen und Institutionen

  • German Cancer Consortium (DKTK), Partner Site Berlin, a Partnership between DKFZ and Charité - Universitätsmedizin Berlin, Berlin 10117, Germany.
  • Charite Comprehensive Cancer Center, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin 10117, Germany.
  • Department of Hematology, Oncology and Cancer Immunology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin 12203, Germ…
  • National Center for Tumor Diseases (NCT), NCT Berlin, a Partnership between DKFZ, Charité Universitätsmedizin, BIH and MDC, Berlin 10117, Germany.
  • Department of Nuclear Medicine, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin 13353, Germany.
  • Department of Pediatric Oncology and Hematology, Campus Virchow Klinikum, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin 13353, Germany.

ORCID-Profile: Damian T Rieke, Hedwig E Deubzer, David Capper, Ulrich Keller, Simon Schallenberg

Förderung

  • NCT Molecular Precision Oncology Program, DKFZ, and DKTK

Zitieren

APA

Rieke, D. T., Schwartz, S., Ochsenreither, S., Chapuy, B., Amthauer, H., Deubzer, H. E., Lehmann, A., Keilholz, U., Wardelmann, E., Vokuhl, C., Eggert, A., Fröhling, S., Horst, D., Capper, D., Keller, U., Dragomir, M. P., & Schallenberg, S. (2026). Comprehensive molecular analyses for diagnosis and treatment guidance in an adult neuroblastoma patient. The Oncologist, 31(5). https://doi.org/10.1093/oncolo/oyag132

Vancouver

Rieke DT, Schwartz S, Ochsenreither S, Chapuy B, Amthauer H, Deubzer HE, et al. Comprehensive molecular analyses for diagnosis and treatment guidance in an adult neuroblastoma patient. The Oncologist. 2026;31(5). doi:10.1093/oncolo/oyag132

BibTeX
@article{Rieke2026,
  author = {Rieke, Damian T and Schwartz, Stefan and Ochsenreither, Sebastian and Chapuy, Björn and Amthauer, Holger and Deubzer, Hedwig E and Lehmann, Annika and Keilholz, Ulrich and Wardelmann, Eva and Vokuhl, Christian and Eggert, Angelika and Fröhling, Stefan and Horst, David and Capper, David and Keller, Ulrich and Dragomir, Mihnea P and Schallenberg, Simon},
  title = {Comprehensive molecular analyses for diagnosis and treatment guidance in an adult neuroblastoma patient},
  journal = {The Oncologist},
  year = {2026},
  volume = {31},
  number = {5},
  doi = {10.1093/oncolo/oyag132}
}
Kostenlos starten →